TODDE, SERGIO CAMILLO
 Distribuzione geografica
Continente #
NA - Nord America 9.431
AS - Asia 5.481
EU - Europa 4.294
SA - Sud America 652
Continente sconosciuto - Info sul continente non disponibili 413
AF - Africa 123
OC - Oceania 10
Totale 20.404
Nazione #
US - Stati Uniti d'America 8.963
VN - Vietnam 1.646
SG - Singapore 1.411
IT - Italia 1.145
CN - Cina 1.036
DE - Germania 673
HK - Hong Kong 540
RU - Federazione Russa 500
SE - Svezia 490
BR - Brasile 478
CA - Canada 383
IE - Irlanda 306
GB - Regno Unito 253
UA - Ucraina 239
BD - Bangladesh 166
FR - Francia 160
FI - Finlandia 149
IN - India 148
AT - Austria 89
KR - Corea 89
ID - Indonesia 69
AR - Argentina 65
TR - Turchia 54
NL - Olanda 53
IQ - Iraq 52
ZA - Sudafrica 46
JP - Giappone 40
PK - Pakistan 40
PL - Polonia 39
ES - Italia 37
DK - Danimarca 36
SA - Arabia Saudita 36
MX - Messico 33
EC - Ecuador 32
PH - Filippine 28
CO - Colombia 27
BE - Belgio 22
MA - Marocco 17
CH - Svizzera 15
IR - Iran 15
MY - Malesia 15
CZ - Repubblica Ceca 14
BG - Bulgaria 13
UZ - Uzbekistan 13
VE - Venezuela 13
KE - Kenya 12
AE - Emirati Arabi Uniti 11
CL - Cile 11
TN - Tunisia 11
JM - Giamaica 10
RO - Romania 10
PE - Perù 9
GR - Grecia 8
PT - Portogallo 8
DO - Repubblica Dominicana 7
EG - Egitto 7
HN - Honduras 7
KZ - Kazakistan 7
PY - Paraguay 7
SK - Slovacchia (Repubblica Slovacca) 7
TH - Thailandia 7
AU - Australia 6
JO - Giordania 6
LT - Lituania 6
NP - Nepal 6
OM - Oman 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
BO - Bolivia 5
CR - Costa Rica 5
DZ - Algeria 5
EU - Europa 5
LB - Libano 5
NI - Nicaragua 5
TW - Taiwan 5
ET - Etiopia 4
LV - Lettonia 4
MK - Macedonia 4
NG - Nigeria 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SN - Senegal 4
AO - Angola 3
IL - Israele 3
KG - Kirghizistan 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
PA - Panama 3
UY - Uruguay 3
BS - Bahamas 2
GE - Georgia 2
GH - Ghana 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
LY - Libia 2
ME - Montenegro 2
MN - Mongolia 2
MQ - Martinica 2
Totale 19.975
Città #
Ann Arbor 1.568
Ashburn 933
Singapore 816
San Jose 542
Hong Kong 515
Ho Chi Minh City 511
Hanoi 455
Fairfield 434
Houston 397
Woodbridge 359
Wilmington 332
Chandler 321
Milan 291
Dublin 288
Jacksonville 250
New York 245
Toronto 243
Santa Clara 212
Frankfurt am Main 207
Dearborn 194
Council Bluffs 176
Seattle 175
Dallas 173
Los Angeles 169
Beijing 162
Hefei 136
Cambridge 135
Chicago 127
Munich 121
Princeton 114
The Dalles 100
Rome 88
Nanjing 83
Seoul 77
Helsinki 72
Vienna 67
Lauterbourg 62
Da Nang 61
Shanghai 60
Altamura 59
Boardman 56
São Paulo 53
Buffalo 51
Lawrence 49
Haiphong 48
Columbus 47
Jakarta 46
Orem 43
Moscow 41
Lachine 39
San Diego 37
Ninh Bình 33
Turin 32
Quận Bình Thạnh 31
Biên Hòa 30
Phoenix 30
Tokyo 30
Denver 29
London 29
Guangzhou 27
Ha Long 27
Hải Dương 27
Montreal 27
Shenyang 27
Warsaw 25
Changsha 24
Nürnberg 24
Thái Nguyên 24
Hebei 23
Atlanta 22
Can Tho 22
Tianjin 22
Brussels 21
Lissone 21
Dhaka 20
Nanchang 20
Brooklyn 19
Falls Church 19
Figino 19
San Francisco 19
Turku 19
Andover 18
Bologna 18
Stockholm 18
Chennai 17
Dong Ket 17
Genoa 17
Jinan 17
Salt Lake City 17
Baghdad 16
Fremont 16
Jiaxing 16
Naples 16
Newark 16
Ottawa 16
Bắc Ninh 15
Jeddah 15
Montréal 15
Rio de Janeiro 15
Amsterdam 14
Totale 12.891
Nome #
Radio-chemotherapy and metformin selectively modulate the heterogeneous landscape of glioma with ribosome biogenesis, long non coding RNA and immune-escape markers as major player 820
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 583
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 552
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 544
Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: A PET imaging and metabolomics-mass-spectrometry study 538
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 476
Cholinergic ligand [C-11]MP4A: Improved 4-acetoxypiperidine precursor synthesis via LC-APCI/MS characterisation and improved radioligand HPLC purification 462
In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416 462
Produzione e verifiche di qualità dei radiofarmaci estemporanei per PET e terapia 438
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 430
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 423
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 419
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma 391
PET imaging and single-cell RNA sequencing glioma microenvironment assessment after RT combined therapy 383
Improved synthesis and radiolabeling of [C-11]MP4A, a suitable ligand for the investigation of the cholinergic system using PET 380
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 376
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 359
EANM Guideline on the validation of analytical methods for radiopharmaceuticals 339
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 337
Highlight selection of radiochemistry and radiopharmacy developments by editorial board 330
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation 327
PET radiopharmacy and automation 325
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 320
Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies 314
Sperimentazione clinica con radiofarmaci 304
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework 294
European regulations for the introduction of novel radiopharmaceuticals in the clinical setting 291
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells 289
Synthesis and in vivo evaluation of [11C]ICI 118551 as a putative subtype selective β2-adrenergic radioligand 285
Quality Control in the Production of Radiopharmaceuticals 283
Synthesis and carbon-11 labeling of (R)- and (S)-Thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for Positron Emission Tomography 282
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 276
Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application 274
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 274
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand 271
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals 270
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) 270
Radiosynthesis of [123I]βCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain 264
Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons 262
Rsdiofarmaci marcati con fluoro-18 262
Measurement and control of the air contamination generated in a medical cyclotron facility for PET radiopharmaceuticals 260
Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors 259
Systemic and cerebral kinetics of 16α[18F]fluoro-17β-estradiol: A ligand for the in vivo assessment of estrogen receptor binding parameters 254
Synthesis and Biodistribution of (R,S)-[O-Methyl-11C]-1-[3-(5-Methoxy-1,2,3,4-Tetrahydro-1-Naphtalenyl)Propyl]-4-Phenylpiperazine (PNU-157760), A Putative Radioligand for 5-HT1A Receptors 250
Sensitive GC-MS method for the determination of specific-activity of 16a[18F]Fluoro-estra-1,3,5(10)-triene-3,17b-diol 248
Preparation of [11C]radioligands with high specific radioactivity on a commercial PET tracer synthesizer 246
Automation of [C-11]acyl chloride syntheses using commercially available C-11-modules 239
Synthesis and in vivo evaluation of [C-11]CGP62349, a new GABA(B) receptor antagonist 237
High yield synthesis of [11C]-acetone through selective quenching of methyl lithium 234
Intake risk and dose evaluation methods for workers in radiochemistry labs of a medical cyclotron facility 226
Decommissioning procedures for an 11 MeV self-shielded medical cyclotron after 16 years of working time 222
Guidance on validation and qualification of processes and operations involving radiopharmaceuticals 218
Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals 215
EANM guideline on quality risk management for radiopharmaceuticals 204
Synthesis of [O-methyl-11c]fluvoxamine-a potential serotonin uptake site radioligand 198
PET in psychopharmacology 197
Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A2A receptor system using positron emission tomography [2] 190
From radiotracer to radiopharmaceutical: a philosophical approach 185
Classificazione ambientale 183
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals 177
Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken' 167
Highlight selection of radiochemistry and radiopharmacy developments by editorial board 163
Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals 158
A PET follow-up study of recovery after stroke in acute aphasics 157
Guidance on current good radiopharmacy practice for the small-scale preparation of radiopharmaceuticals using automated modules: A European perspective 156
Mild synthesis of [N-methyl-11C]-isovaleroyl-(L)-carnitine. The usefulness of a tritium approach. 146
Automated fluorine-18 radiolabeling via an alkyne–azide cycloaddition reaction on a dual peptide-functionalized liposome surface for in vivo PET imaging 140
Application of molecular imaging as potential prognostic biomarker for triple-negative breast cancer (TNBC) 76
The clinical translation process in Europe 20
Totale 20.404
Categoria #
all - tutte 61.238
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.238


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022821 0 0 168 136 35 59 62 69 49 59 77 107
2022/20231.344 164 387 84 134 100 197 26 78 71 19 57 27
2023/20241.109 44 40 56 39 147 310 211 40 85 12 8 117
2024/20252.572 137 251 120 98 217 179 202 158 239 341 207 423
2025/20267.840 1.558 742 508 736 704 356 913 311 510 535 464 503
2026/20271.051 319 450 282 0 0 0 0 0 0 0 0 0
Totale 20.404